{"SPADE_N_13558": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13558", "Peptide Name": "OaBac5gamma (natural AMPs; Pro-rich; PrAMPs, ovine cathelicidin, sheep, ruminant, mammals, animals)", "Source": "Fermented milk drink Kefir.", "Family": "Not found", "Gene": "Not found", "Sequence": "RFRPPILRPPIRPPFRPPFRPPVRPPIRPPFRPPFRPPIGPFP", "Sequence Length": 43, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Anti-MRSA"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 5127.19, "PI": 12.0, "Hydrophobicity": -0.8, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Anderson RC, Yu PL.2003", "Reference": "Biochem Biophys Res Commun. 2003 Dec 26;312(4):1139-46. doi: 10.1016/j.bbrc.2003.11.045.PubMed", "Title": "Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils"}], "Frequent Amino Acids": "PRF", "Absent Amino Acids": "ACDEHKMNOQSTUWY", "Basic Residues": 10, "Acidic Residues": 0, "Hydrophobic Residues": 32, "Polar Residues": 11, "Positive Residues": 10, "Negative Residues": 0, "Net Charge": 10, "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (97.67%) toOaBac5A variant of OaBac5 (isolated and tested). P: 47%; R: 23%; F: 14%.  GRAVY: -0.80; M. Wt.: 5127.282; Mol formula: C251H383N73O44; Mol Ex Coeff: 0.Activity: Active against E. coli 0157:H7 (MIC 6 ug/ml),  S. aureus 1056 MRSA (MIC 10 ug/ml), and C. albicans 3153A (MIC 45 ug/ml).antimicrobial robustness: in 100 mM NaCl, the peptide lost activity against MRSA, its activity against Escherichia coli was reduced to MIC 22 ug/ml, but there was little change against Candida. The original has been replaced due to poor antimicrobial activity Updated 5/2023.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02522", "Similarity": 0.9767441860465116, "Sequence": "RFRPPIRRPPIRPPFRPPFRPPVRPPIRPPFRPPFRPPIGPFP"}, {"SPADE_ID": "SPADE_N_13261", "Similarity": 0.96, "Sequence": "RFRPPIRRPPIRPPFRPPFRPPVRP"}, {"SPADE_ID": "SPADE_UN_21034", "Similarity": 0.96, "Sequence": "RFRPPIRRPPIRPPFRPPFRPPVRP"}]}}}